ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

The FDA signed off on WHOOP's blood pressure analysis tool after months of negotiation. WHOOP will remove labeling that flagged readings as normal or elevated and switch to wellness-focused language. The wearable never disabled blood pressure support during the dispute.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Clair Health raises $11.6M for noninvasive hormone monitor